Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 ,inter alia, to consider and approve As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has informed BSE that its Board of Directors will meet on 11th December 2025 to consider a proposal for raising funds. The funds could be raised through one or more instruments including equity shares, convertible securities, warrants, or debt securities. The company may use methods such as private placement, preferential issue, qualified institutions placement (QIP), or combinations thereof. The trading window for designated persons has been closed till 48 hours after the outcome is announced. No specific size, pricing, or investor details have been disclosed yet.
This is a standard pre-board intimation signalling a potential capital raise, which could lead to equity dilution. Shareholders should watch for the 11th December outcome for details on instrument type, size, and pricing, as these will determine the actual impact on the stock.